JAC Advance Access originally published online on October 19, 2009
Journal of Antimicrobial Chemotherapy 2009 64(6):1347; doi:10.1093/jac/dkp379
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
© The Author 2009. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. All rights reserved. For Permissions, please e-mail: journals.permissions@oxfordjournals.org
Letter to the Editor |
Comment on: Developments in outpatient parenteral antimicrobial therapy (OPAT) for Gram-positive infections in Europe, and the potential impact of daptomycin
1 Laboratory of Medical Microbiology, Vaccine & Infectious Disease Institute, University of Antwerp, Antwerp, Belgium 2 Centre for General Practice, Vaccine & Infectious Disease Institute, University of Antwerp, Antwerp, Belgium 3 Research Foundation - Flanders, Brussels, Belgium
* Corresponding author. E-mail: niels.adriaenssens@ua.ac.be
Keywords: antibiotic use , route of administration , drug consumption , pharmacoepidemiology , ambulatory care
| The first 10% of the full text of this article appears below. |
Sir,
With great interest we have read the review by Dilip Nathwani in
| Transparency declarations |
|---|